Facility Design and Engineering

Jan 19, 2018
By BioPharm International Editors
GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.
Jan 11, 2018
By BioPharm International Editors
Athenex is moving forward with the construction of a new 320,000-square-foot pharmaceutical manufacturing facility in Dunkirk, NY, and has hired the German engineering firm, M+W, to design and construct the facility.
Jan 11, 2018
By BioPharm International Editors
Sartorius Stedim Biotech will equip Abzena’s contract development and manufacturing facilities in Bristol, PA, and San Diego, CA, with single-use equipment and scale-up technologies.
Jan 08, 2018
By BioPharm International Editors
AptarGroup’s Landfill Free Certification program addresses the issue of waste production from pharmaceutical manufacturing processes by prompting its facilities to reduce and reuse operation waste.
Jan 05, 2018
By BioPharm International Editors
FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.
Jan 04, 2018
By BioPharm International Editors
The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.
Jan 01, 2018
BioPharm International
Recent investments show expansion activity in cell culture facilities.
Dec 28, 2017
By BioPharm International Editors
The biotechnology company has filed for FDA approval of a new plasma manufacturing facility in Covington, GA, to support its immunology franchise.
Dec 13, 2017
By BioPharm International Editors
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
Dec 13, 2017
By BioPharm International Editors
In partnership with Indian pharmaceutical firm, Torrent Pharmaceuticals, Novo Nordisk has expanded an insulin manufacturing facility at Torrent’s Indrad, Gujarat, India site.
native1_300x100
lorem ipsum